- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 20-08-2026: Press Release
20-08-2026 | 08:52 am
20-08-2026 | 08:52 am
Glenmark Pharma received US approval for its Fluticasone Propionate Nasal Spray, a generic equivalent to Flonase®. This boosts their US respiratory portfolio, targeting a market with $295.2 million in annual sales.
No comments yet. Be the first to comment!